Matthew R. Silver

Davis Polk advised the representatives of the several underwriters in connection with a $191.5 million initial public offering of common stock of Turning Point Therapeutics, Inc…

Davis Polk advised Banco Santander Chile in connection with its Regulation S offering in Switzerland of CHF150 million aggregate principal amount of 0.384% fixed-rate notes due 2024. Banco…

Davis Polk advised the joint book-running managers on the SEC-registered offering by Lam Research Corporation of $750 million aggregate principal amount of its 3.750% senior notes due 2026,…

Davis Polk advised Laboratorios Farmacéuticos Rovi, S.A. on its Rule 144A/Regulation S follow-on offering of 5,517,241 of its ordinary shares to raise gross proceeds of approximately €80…

Davis Polk advised Tyson Foods, Inc. in connection with its SEC-registered offerings of $900 million aggregate principal amount of senior notes in two series, consisting of $400 million…

Davis Polk advised the sole representative of the initial purchasers on a Rule 144A/Regulation S debt offering by Carvana Co. of $350 million aggregate principal amount of its 8.875% senior…

Davis Polk advised Banco Santander Chile in connection with its Regulation S offering in Switzerland of CHF115 million aggregate principal amount of 0.441% fixed-rate notes due 2023. Banco…

Davis Polk advised the sole book-running manager in connection with the $24.7 million public offering of common stock of Maxwell Technologies, Inc. The common stock is listed on the…

Davis Polk is advising ORIX Corporation USA on its acquisition of NXT Capital Inc. The transaction, which is expected to close in August 2018, is subject to customary closing conditions and…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of €1.25 billion aggregate principal amount of floating-rate senior notes due 2021. The Davis Polk…